AAAAAA
Results:
1-15
|
Results: 15
Authors:
Martenson, ED
Hansson, LO
Nilsson, B
von Schoultz, E
Brahme, EM
Ringborg, U
Hansson, J
Citation: Ed. Martenson et al., Serum S-100B protein as a prognostic marker in malignant cutaneous melanoma, J CL ONCOL, 19(3), 2001, pp. 824-831
Authors:
Omholt, K
Platz, A
Ringborg, U
Hansson, J
Citation: K. Omholt et al., Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma, INT J CANC, 92(6), 2001, pp. 839-842
Authors:
Wassberg, C
Thorn, M
Johansson, AM
Bergstrom, R
Berne, B
Ringborg, U
Citation: C. Wassberg et al., Increasing incidence rates of squamous cell carcinoma of the skin in Sweden, ACT DER-VEN, 81(4), 2001, pp. 268-272
Authors:
Platz, A
Ringborg, U
Hansson, J
Citation: A. Platz et al., Hereditary cutaneous melanoma, SEM CANC B, 10(4), 2000, pp. 319-326
Authors:
Karnell, R
Kagedal, B
Lindholm, C
Nilsson, B
Arstrand, K
Ringborg, U
Citation: R. Karnell et al., The value of cysteinyldopa in the follow-up of disseminated malignant melanoma, MELANOMA RE, 10(4), 2000, pp. 363-369
Authors:
Ringborg, U
Levitt, S
Citation: U. Ringborg et S. Levitt, Jerzy Einhorn, MD - A memorial, AM J CL ONC, 23(5), 2000, pp. 538-538
Authors:
Gillgren, P
Mansson-Brahme, E
Frisell, J
Johansson, H
Larsson, O
Ringborg, U
Citation: P. Gillgren et al., A prospective population-based study of cutaneous malignant melanoma of the head and neck, LARYNGOSCOP, 110(9), 2000, pp. 1498-1504
Authors:
Hashemi, J
Platz, A
Ueno, T
Stierner, U
Ringborg, U
Hansson, J
Citation: J. Hashemi et al., CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas, CANCER RES, 60(24), 2000, pp. 6864-6867
Authors:
Cohn-Cedermark, G
Rutqvist, LE
Andersson, R
Breivald, M
Ingvar, C
Johansson, H
Jonsson, PE
Krysander, L
Lindholm, C
Ringborg, U
Citation: G. Cohn-cedermark et al., Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm, CANCER, 89(7), 2000, pp. 1495-1501
Authors:
Cohn-Cedermark, G
Mansson-Brahme, E
Rutqvist, LE
Larsson, O
Johansson, H
Ringborg, U
Citation: G. Cohn-cedermark et al., Trends in mortality from malignant melanoma in Sweden, 1970-1996, CANCER, 89(2), 2000, pp. 348-355
Authors:
Bergenmar, M
Ringborg, U
Brahme, EM
Brandberg, Y
Larsson, O
Citation: M. Bergenmar et al., Nodular histogenetic type - the most significant factor for thick melanoma: implications for prevention. Response, MELANOMA RE, 9(3), 1999, pp. 304-304
Authors:
Gillgren, P
Mansson-Brahme, E
Frisell, J
Johansson, H
Larsson, O
Ringborg, U
Citation: P. Gillgren et al., Epidemiological characteristics of cutaneous malignant melanoma of the head and neck - A population-based study, ACTA ONCOL, 38(8), 1999, pp. 1069-1074
Authors:
Cohn-Cedermark, G
Mansson-Brahme, E
Rutqvist, LE
Larsson, O
Singnomklao, T
Ringborg, U
Citation: G. Cohn-cedermark et al., Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma, ACTA ONCOL, 38(5), 1999, pp. 549-557
Authors:
Wassberg, C
Thorn, M
Yuen, J
Hakulinen, T
Ringborg, U
Citation: C. Wassberg et al., Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ, INT J CANC, 83(3), 1999, pp. 314-317
Authors:
Wassberg, C
Thorn, M
Yuen, J
Ringborg, U
Hakulinen, T
Citation: C. Wassberg et al., Second primary cancers in patients with squamous cell carcinoma of the skin: A population-based study in Sweden, INT J CANC, 80(4), 1999, pp. 511-515
Risultati:
1-15
|